or Try an Advanced Search...

    Technical Analysis for FBIOP - Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

    Grade Last Price % Change Price Change
    F 5.10 0.39% 0.02
    FBIOP closed up 0.39 percent on Friday, November 15, 2024, on 70 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical FBIOP trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    50 DMA Resistance Bearish 0.39%
    Outside Day Range Expansion 0.39%
    Down 3 Days in a Row Weakness 0.39%
    Oversold Stochastic Weakness 0.39%
    Earnings Movers Other -0.51%
    Inside Day Range Contraction -0.51%
    Older End-of-Day Signals for FBIOP ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 7 hours ago
    Possible Inside Day about 7 hours ago
    Up 2% about 11 hours ago
    Up 1% about 11 hours ago
    Down 2 % 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    FBIOP Chart by TradingView
    Basic chart:

    Profile

    Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Life Sciences Immunotherapy Autoimmune Disease Virotherapy Treatment Of Autoimmune Disease

    Is FBIOP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Fortress Biotech: Q3 Earnings Snapshot
    Nov 14 Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
    Nov 14 Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
    Nov 12 Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
    Nov 12 Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
    Nov 12 Mustang Bio Receives Positive Listing Determination from Nasdaq
    Nov 4 Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
    Oct 31 Fortress Biotech Insiders Placed Bullish Bets Worth US$4.49m
    Oct 25 Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares
    Oct 25 Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
    See more FBIOP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.473
    52 Week Low 4.86
    Average Volume 19,374
    200-Day Moving Average 11.15
    50-Day Moving Average 5.46
    20-Day Moving Average 5.55
    10-Day Moving Average 5.25
    Average True Range 0.40
    RSI (14) 38.27
    ADX 19.34
    +DI 17.83
    -DI 18.96
    Chandelier Exit (Long, 3 ATRs) 5.49
    Chandelier Exit (Short, 3 ATRs) 6.22
    Upper Bollinger Bands 6.25
    Lower Bollinger Band 4.85
    Percent B (%b) 0.18
    BandWidth 25.13
    MACD Line -0.14
    MACD Signal Line -0.09
    MACD Histogram -0.0533
    Fundamentals Value
    Market Cap 289.07 Million
    Num Shares 56.7 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -5.91
    Price-to-Sales 1.20
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.39
    Resistance 3 (R3) 5.40 5.31 5.34
    Resistance 2 (R2) 5.31 5.24 5.31 5.33
    Resistance 1 (R1) 5.20 5.19 5.16 5.20 5.31
    Pivot Point 5.12 5.12 5.09 5.11 5.12
    Support 1 (S1) 5.01 5.04 4.97 5.00 4.89
    Support 2 (S2) 4.92 4.99 4.92 4.87
    Support 3 (S3) 4.82 4.92 4.86
    Support 4 (S4) 4.81